Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Jenkins

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Investigative Radiology|December 24, 1997
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imagingF M Cavagna, F Maggioni, P M Castelli, et al.
Journal of Neurochemistry|May 9, 2000
Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease miceB G Jenkins, P Klivenyi, E Kustermann, et al.
Magnetic Resonance in Medicine|February 1, 1997
Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated apparent diffusion coefficient changes in the peri-infarct zone during focal cerebral ischemiaG Zaharchuk, H Hara, P L Huang, et al.
Neuroscience|February 1, 1995
Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington diseaseL H Burns, P Pakzaban, T W Deacon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 24, 1998
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's diseaseR T Matthews, L Yang, B G Jenkins, et al.
Journal of Neurochemistry|April 12, 2001
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementationO A Andreassen, B G Jenkins, A Dedeoglu, et al.
Brain Research|May 30, 1994
Malonate produces striatal lesions by indirect NMDA receptor activationR Henshaw, B G Jenkins, J B Schulz, et al.
The American Journal of Physiology|April 1, 1997
Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniquesJ B Schulz, N Panahian, Y I Chen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1996
Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imagingB G Jenkins, E Brouillet, Y C Chen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Riluzole therapy in Huntington's disease (HD)H D Rosas, W J Koroshetz, B G Jenkins, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Investigative Radiology|December 24, 1997
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imagingF M Cavagna, F Maggioni, P M Castelli, et al.
Journal of Neurochemistry|May 9, 2000
Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease miceB G Jenkins, P Klivenyi, E Kustermann, et al.
Magnetic Resonance in Medicine|February 1, 1997
Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated apparent diffusion coefficient changes in the peri-infarct zone during focal cerebral ischemiaG Zaharchuk, H Hara, P L Huang, et al.
Neuroscience|February 1, 1995
Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington diseaseL H Burns, P Pakzaban, T W Deacon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 24, 1998
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's diseaseR T Matthews, L Yang, B G Jenkins, et al.
Journal of Neurochemistry|April 12, 2001
Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementationO A Andreassen, B G Jenkins, A Dedeoglu, et al.
Brain Research|May 30, 1994
Malonate produces striatal lesions by indirect NMDA receptor activationR Henshaw, B G Jenkins, J B Schulz, et al.
The American Journal of Physiology|April 1, 1997
Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniquesJ B Schulz, N Panahian, Y I Chen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1996
Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imagingB G Jenkins, E Brouillet, Y C Chen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Riluzole therapy in Huntington's disease (HD)H D Rosas, W J Koroshetz, B G Jenkins, et al.
Pageof 6